MeSH term
Frequency | Condition_Probility | Humans | 21 | 0.0 |
Cell Cycle Proteins/biosynthesis/*genetics | 2 | 13.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 2 | 1.0 |
Female | 5 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Male | 7 | 0.0 |
Nuclear Proteins/biosynthesis/*genetics | 2 | 5.0 |
Research Support, Non-U.S. Gov't | 20 | 0.0 |
Middle Aged | 2 | 0.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
*Genes, myc | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Base Sequence | 7 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Replication Origin | 3 | 12.0 |
Amino Acid Sequence | 7 | 0.0 |
Animals | 7 | 0.0 |
Mice | 4 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Protein Binding | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Cell Cycle | 2 | 0.0 |
Cell Cycle Proteins/*metabolism | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
G1 Phase | 2 | 0.0 |
Nuclear Proteins/*metabolism | 3 | 0.0 |
*Saccharomyces cerevisiae Proteins | 4 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Cell Line | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
DNA Replication/genetics/*physiology | 2 | 33.0 |
Phosphorylation | 3 | 0.0 |
Saccharomyces cerevisiae/genetics/metabolism | 2 | 1.0 |
Substrate Specificity | 2 | 0.0 |
S Phase | 2 | 0.0 |
DNA Replication | 3 | 0.0 |
Hela Cells | 5 | 0.0 |
*Cell Cycle Proteins | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Cell Cycle Proteins/*genetics | 2 | 1.0 |
Cells, Cultured | 2 | 0.0 |
*DNA Replication | 6 | 2.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Xenopus | 2 | 0.0 |
*Xenopus Proteins | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Cell Cycle Proteins/genetics/*metabolism | 2 | 1.0 |
